Mechanisms of disease: Protease functions in intestinal mucosal pathobiology

Nature Clinical Practice Gastroenterology and Hepatology

Volumn 4, Issue 7, 2007, Pages 393-402

  Antalis, Toni M ^a   Shea Donohue, Terez ^a   Vogel, Stefanie N ^a   Sears, Cynthia ^b   Fasano, Alessio ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^b JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOKINE; DIPEPTIDYL PEPTIDASE IV; ENZYME PRECURSOR; G PROTEIN COUPLED RECEPTOR; GROWTH FACTOR; MATRIPTASE; MATRIX METALLOPROTEINASE 14; PEPTIDASE; PROTEINASE; SCLEROPROTEIN; PEPTIDE HYDROLASE; PROTEINASE ACTIVATED RECEPTOR;

CARDIOVASCULAR SYSTEM; CELL COMPARTMENTALIZATION; CELL TYPE; DIGESTIVE FUNCTION; ENTERITIS; ENVIRONMENTAL CHANGE; GASTROINTESTINAL DISEASE; HISTOPATHOLOGY; HUMAN; INTESTINE ABSORPTION; INTESTINE EPITHELIUM CELL; INTESTINE FLORA; INTESTINE MUCOSA; MOLECULAR MECHANICS; MUCOSAL IMMUNITY; NERVOUS SYSTEM; PARASITE; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN FUNCTION; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; WOUND HEALING; ANIMAL; ENTEROPATHY; METABOLISM; PATHOLOGY; PATHOPHYSIOLOGY; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY;

ANIMALS; HUMANS; INFLAMMATORY BOWEL DISEASES; INTESTINAL DISEASES; INTESTINAL MUCOSA; PEPTIDE HYDROLASES; RECEPTORS, PROTEINASE-ACTIVATED; RISK ASSESSMENT; SENSITIVITY AND SPECIFICITY; SIGNAL TRANSDUCTION;

EID: 34447626985     PISSN: 17434378     EISSN: 17434386     Source Type: Journal    
DOI: 10.1038/ncpgasthep0846     Document Type: Review

References (87)

1. Turk B (2006) Targeting proteases: Successes, failures and future prospects. Nat Rev Drug Discov 5: 785-799
2. Puente XS et al. (2005) A genomic view of the complexity of mammalian proteolytic systems. Biochem Soc Trans 33: 331-334
3. Neurath H (1999) Proteolytic enzymes, past and future. Proc Natl Acad Sci USA 96: 10962-10963
4. Medina C and Radomski MW (2006) Role of matrix metalloproteinases in intestinal inflammation. J Pharmacol Exp Ther 3l8: 933-938
5. Neurath H and Walsh KA (1976) Role of proteolytic enzymes in biological regulation (a review). Proc Natl Acad Sci USA 73: 3825-3832
6. Eggermont E et al. (1971) Distribution of enterokinase activity in the human intestine. Acta Gastroenterol Belg 34: 655-662
7. Truninger K et al. (2001) Genetic aspects of chronic pancreatitis: insights into aetiopathogenesis and clinical implications. Swiss Med Wkly 131: 565-574
8. Netzel-Arnett S et al. (2002) Collagen dissolution by keratinocytes requires cell surface plasminogen activation and matrix metalloproteinase activity. J Biol Chem 277: 45154-45161
9. Yana I and Weiss SJ (2000) Regulation of membrane type-1 matrix metalloproteinase activation by proprotein convertases. Mol Biol Cell 11:2387-2401
10. Jacob C et al. (2005) Mast cell tryptase controls paracellular permeability of the intestine. Role of pratease-activated receptor 2 and beta-arrestins. J Biol Chem 280: 31936-31948
11. Hooper JD et al. (2001) Type II transmembrane serine proteases. Insights into an emerging class of cell surface proteolytic enzymes. J Biol Chem 276: 857-860
12. Netzel-Arnett S et al. (2003) Membrane anchored serine proteases: a rapidly expanding group of cell surface proteolytic enzymes with potential roles in cancer. Cancer Metastasis Rev 22: 237-258
13. Lorey S et al. (2002) Transcellular proteolysis demonstrated by novel cell surface-associated substrates of dipeptidyl peptidase IV (CD26). J Biol Chem 277: 33170-33177
14. Plow EF and Miles LA (1990) Plasminogen receptors in the mediation of pericellular proteolysis. Cell Differ Dev 32: 293-298
15. Antalis TM and Lawrence DA (2004) Serpin mutagenesis. Methods 32: 130-140
16. Herz J and Strickland DK (2001) LRP: A multifunctional scavenger and signaling receptor. J Clin Invest 108: 779-784
17. Gschwind A et al. (2001) Cell communication networks: Epidermal growth factor receptor transactivation as the paradigm for interreceptor signal transmission. Oncogene 20: 1594-1600
18. Ohtsu H et al. (2006) ADAMs as mediators of EGF receptor transactivation by G protein-coupled receptors. Am J Physiol Cell Physiol 291: C1-C10
19. Steinhoff M et al. (2005) Proteinase-activated receptors: transducers of proteinase-mediated signaling in inflammation and immune response. Endocr Rev 26: 1-43
20. MacNaughton WK (2005) Epithelial effects of proteinase-activated receptors in the gastrointestinal tract. Mem Inst Oswaldo Cruz 100 (Suppl 1): 211-215
21. Vergnolle N (2000) Review article: Proteinase-activated receptors - novel signals for gastrointestinal pathophysiology. Aliment Pharmacol Ther 14: 257-266
22. Kawabata A (2003) Gastrointestinal functions of proteinase-activated receptors. Life Sci 74: 247-254
23. Coughlin SR (1999) How the protease thrombin talks to cells. Proc Natl Acad Sci USA 96: 11023-11027
24. Nakanishi-Matsui M et al. (2000) PAR3 is a cofactor for PAR4 activation by thrombin. Nature 404: 609-613
25. Cottrell GS et al. (2004) Trypsin IV, a novel agonist of protease-activated receptors 2 anc 4. J Biol Chem 279: 13532-13539
26. Cottrell GS et al. (2003) Protease-activated receptor 2: activation, signalling and function. Biochem Soc Trans 31: 1191-1197
27. Dulon S et al. (2005) Pseudomonas aeruginosa elastase disables proteinase-activated receptor 2 in respiratory epithelial cells. Am J Respir Cell Mol Biol 32: 411-419
28. Dulon S et al. (2003) Proteinase-activated receptor-2 and human lung epitheliall cells: Disarming by neutrophil serine proteinases. Am J Respir Cell Mol Biol 28: 339-346
29. Dery O et al. (1998) Proteinase-activated receptors: Novel mechanisms of signaling by serine proteases. Am J Physiol 274 C1429-C1452
30. Vergnolle N (2005) Clinical relevance of proteinase activated receptors (pars) in the gut. Gut 54: 867-874
31. Gloro R et al. (2005) Protease-activated receptors. potential therapeutic targets in irritable bowel syndrome? Expert Opin Ther Thargets 9: 1079-1095
32. Ossovskaya VS and Bunnett NW (2004) Protease-activated receptors: contribution to physiology and disease. Physiol Rev 84: 579-621
33. Dano K et al. (2005) Plasminogen activation and cancer. Thromb Haemost 93: 676-681
34. Cenac N et al. (2002) Induction of intestinal inflammation in mouse by activation of proteinase-activated receptor-2. Am J Pathol 161: 1903-1915
35. Cenac N et al. (2004) PAR2 activation alters colonic paracellular permeability in mice via IFN-gamma-dependent and -Independent pathways. J Physiol 558: 913-925
36. Wang W et al. (2000) Human zonulin, a potential modulator of intestinal tight junctions. J Cell Sci 113: 4435-4440
37. Fasano A et al. (2000) Zonulin, a newly discovered modulator of intestinal permeability, and its expression in coeliac disease. Lancet 355: 1518-1519
38. El Asmar R et al. (2002) Host-dependent zonulin secretion causes the impairment of the small intestine barrier function after bacterial exposure. Gastroenterology 123: 1607-1615
39. Clemente MG et al. (2003) Early effects of gliadin on enterocyte intracellular signalling involved in intestinal barrier function. Gut 52: 218-223
40. Drago S et al. (2006) Gliadin, zonulin and gut permeability: effects on celiac and non-celiac intestinal mucosa and intestinal cell lines. Scand J Gastroenterol 41: 408-419
41. Fasano A et al. (1995) Zonula occludens toxin modulates tight junctions through protein kinase C-dependent actin reorganization, in vitro. J Clin Invest 96: 710-720
42. Fasano A (2001) Pathological and therapeutical implications of macromolecule passage through the tight junction. In Tight Junctions 697-722, Boca Raton: CRC Press
43. Weeks CS et al. (2006) Matrix metalloproteinase-7 activation of mouse paneth cell pro-alpha-defensins: SER43 ↓ ILE44 proteolysis enables membrane-disruptive activity. J Biol Chem 281: 28932-28942
44. Wilson CL et al. (1999) Regulation of intestinal alpha-defensin activation by the metalloproteinase matrilysin in innate host defense. Science 286: 113-117
45. Li CK et al. (2004) Impaired immunity to intestinal bacterial infection in stromelysin-1 (matrix metalloproteinase-3)-deficient mice. J Immunol 173: 5171-5179
46. Hansen KK et al. (2005) A major role for proteolytic activity and proteinase-activated receptor-2 in the pathogenesis of infectious colitis. Proc Natl Acad Sci USA 102: 8363-8368
47. Shafer WM et al. (1991) Human lysosomal cathepsin G and granzyme B share a functionally conserved broad spectrum antibacterial peptide. J Biol Chem 266: 112-116
48. Smith PD et al. (2005) Intestinal macrophages: Unique effector cells of the innate immune system. Immunol Rev 206: 149-159
49. Anthony RM et al. (2006) Memory T(H)2 cells induce alternatively activated macrophages to mediate protection against nematode parasites. Nat Med 12: 955-960
50. Kokai-Kun JF et al. (2000) Elastase in intestinal mucus enhances the cytotoxicity of Shiga toxin type 2d. J Biol Chem 275: 3713-3721
51. Sears CL (2001) The toxins of Bacteroides fragilis. Toxicon 39 1737-1746
52. Sears CL (2000) Molecular physiology and pathophysiology of tight junctions. V. assault of the tight junction by enteric pathogens. Am J Physiol Gastrointest Liver Physiol 279: G1129-G1134
53. Dutta PR et al. (2002) Functional comparison of serine protease autotransporters of enterobacteriaceae. Infect Immun 70: 7105-7113
54. 1 protease. Int J Biochem Cell Biol 38: 1244-1248
55. Na X et al. (2005) Clostridium difficile toxin B activates the EGF receptor and the ERK/MAP kinase pathway in human colonocytes. Gastroenterology 128: 1002-1011
56. Kosowska K et al. (2002) The Clostridium ramosum IgA proteinase represents a novel type of metalloendopeptidase. J Biol Chem 277: 11987-11994
57. Lee JD and Yen CM (2005) Protease secreted by the infective larvae of Angiostrongylus cantonensis and its role in the penetration of mouse Intestine. Am J Trop Med Hyg 72: 831-836
58. Zhao A et al. (2005) Immune regulation of protease-activated receptor-1 expression in murine small intestine during Nippostrongylus brasiliensis infection. J Immunol 175: 2563-2569
59. Shea-Donohue T et al. (2001) The role of IL-4 in Heligmosomoides polygyrus-induced alterations in murine intestinal epithelial call function. J Immunol 167: 2234-2239
60. Madden KB et al. (2004) Enteric nematodes induce stereotypic STAT6-dependent alterations in intestinal epithelial cell function. J Immunol 172: 5616-5621
61. Shea-Donohue T and Urban JF Jr (2004) Gastrointestinal parasite and host interactions. Curr Opin Gastroenterol 20: 3-9
62. Rhoads ML et al. (2000) Trichuris suis: A secretory chymotrypsin/elastase inhibitor with potential as an immunomodulator. Exp Parasitol 95: 36-44
63. Pfaff AW et al. (2002) Litomosoides sigmodontis cystatin acts as an immunomodulator during experimental filariasis. Int J Parasitol 32: 171-178
64. Dainichi T et al. (2001) Nippocystatin, a cysteine protease inhibitor from Nippostrongylus brasiliensis, inhibits antigen processing and modulates antigen-specific immune response. Infect Immun 69: 7380-7386
65. Andersson M et al. (2003) Ascaris nematodes from pig and human make three antibacterial peptides: Isolation of cecropin P1 and two ASABF peptides. Cell Mol Life Sci 60: 599-606
66. Podolsky DK (2002) Inflammatory bowel disease. N Engl J Med 347: 417-429
67. Uehara A et al. (2003) Neutrophil serine proteinases activate human nonepithelial cells to produce inflammatory cytokines through protease-activated receptor 2. J Immunol 170: 5690-5696
68. Isozaki Y et al. (2006) Anti-tryptase treatment using nafamostat mesilate has a therapeutic effect on experimental colitis. Scand J Gastroenterol 41: 944-953
69. Morohoshi Y et al. (2006) Inhibition of neutrophil elastase prevents the development of murine dextran sulfate sodium-induced colitis. J Gastroenterol 41: 318-324
70. Santana, A et al. (2006) Attenuation of dextran sodium sulphate induced colitis in matrix metalloproteinase-9 deficient mice. World J Gastroenterol 12: 6464-6472
71. Garg P et al. (2006) Selective ablation of matrix metalloproteinase-2 exacerbates experimental colitis: Contrasting role of gelatinases in the pathogenesis of colitis. J Immunol 177 4103-4112
72. Naito Y and Yoshikawa T (2005) Role of matrix metalloproteinases in inflammatory bowel disease. Mol Aspects Med 26: 379-390
73. Kirkegaard T et al. (2004) Tumour necrosis factor-alpha converting enzyme (TACE) activity in human colonic epithelial cells. Clin Exp Immunol 135: 146-153
74. Wang J et al. (2003) Up-regulation and activation of proteinase-activated receptor 2 in early and delayed radiation injury in the rat intestine: Influence of biological activators of proteinase-activated receptor 2. Radiat Res 160: 524-535
75. Yoshida N et al. (2006) Review article: Anti-tryptase therapy in inflammatory bowel disease. Aliment Pharmacol Ther 24 (Suppl 4) 249-255
76. Broughton G et al. (2006) The basic science of wound healing. Plast Reconstr Surg 117: 12S-34S
77. Salmela MT et al. (2004) Collagenase-1 (MMP-1), matrilysin-1 (MMP-7), and stromelysin-2 (MMP-10) are expressed by migrating enterocyles during intestinal wound healing. Scand J Gastroenterol 39: 1095-1104
78. Cao C et al. (2006) Endocytic receptor LRP together with tPA and PAI-1 coordinates Mac-1-dependent macrophage migration. EMBO J 25: 1860-1870
79. Roy R et al. (2006) Making the cut: Protease-mediated regulation of angiogenesis. Exp Cell Res 312: 608-622
80. Danese S et al. (2006) Angiogenesis as a novel component of inflammatory bowel disease pathogenesis. Gastroenterology 130 2060-2073
81. Itoh H and Kataoka H (2002) Roles of hepatocyte growth factor activator (HGFA) and its Inhibitor HAI-1 In the regeneration of injured gastrointestinal mucosa. J Gastroenterol 37 (Suppl 14): 15-21
82. Itoh H et al. (2004) Regeneration of injured intestinal mucosa is impaired in hepatocyte growth factor activator-deficient mice. Gastroenterology 127: 1423-1435
83. Satomi S et al. (2001) A role for membrane-type serine protease (MT-SP1) in intestinal epithelial turnover. Biochem Biophys Res Commun 287: 995-1002
84. Lee SL et al. (2000) Activation of hepatocyte growth factor and urokinase/plasminogen activator by matriptase, an epithelial membrane serine protease. J Biol Chem 275: 36720-36725
85. Netzel-Arnett S et al. (2006) Evidence for a matriptase-prostasin proteolytic cascade regulating terminal epidermal differentiation. J Biol Chem 281: 32941-32945
86. Jin X et al. (2006) Matriptase activates stromelysin (MMO-3) and promotes tumor growth and angiogenesis. Cancer Sci 97: 1327-1334
87. Takeuchi T et al. (2000) Cellular localization of membrane-type serine protease 1 and identification of protease-activated receptor-2 and single-chain urokinase-type plasminogen activator as substrates. J Biol Chem 275: 26333-26342.